207 related articles for article (PubMed ID: 22732410)
1. α1,6-Fucosyltransferase (Fut8) is implicated in vulnerability to elastase-induced emphysema in mice and a possible non-invasive predictive marker for disease progression and exacerbations in chronic obstructive pulmonary disease (COPD).
Kamio K; Yoshida T; Gao C; Ishii T; Ota F; Motegi T; Kobayashi S; Fujinawa R; Ohtsubo K; Kitazume S; Angata T; Azuma A; Gemma A; Nishimura M; Betsuyaku T; Kida K; Taniguchi N
Biochem Biophys Res Commun; 2012 Jul; 424(1):112-7. PubMed ID: 22732410
[TBL] [Abstract][Full Text] [Related]
2. A single dose of lipopolysaccharide into mice with emphysema mimics human chronic obstructive pulmonary disease exacerbation as assessed by micro-computed tomography.
Kobayashi S; Fujinawa R; Ota F; Kobayashi S; Angata T; Ueno M; Maeno T; Kitazume S; Yoshida K; Ishii T; Gao C; Ohtsubo K; Yamaguchi Y; Betsuyaku T; Kida K; Taniguchi N
Am J Respir Cell Mol Biol; 2013 Dec; 49(6):971-7. PubMed ID: 23822858
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity of heterozygous α1,6-fucosyltransferase knock-out mice to cigarette smoke-induced emphysema: implication of aberrant transforming growth factor-β signaling and matrix metalloproteinase gene expression.
Gao C; Maeno T; Ota F; Ueno M; Korekane H; Takamatsu S; Shirato K; Matsumoto A; Kobayashi S; Yoshida K; Kitazume S; Ohtsubo K; Betsuyaku T; Taniguchi N
J Biol Chem; 2012 May; 287(20):16699-708. PubMed ID: 22433854
[TBL] [Abstract][Full Text] [Related]
4. Relationship between plasma matrix metalloproteinase levels, pulmonary function, bronchodilator response, and emphysema severity.
Koo HK; Hong Y; Lim MN; Yim JJ; Kim WJ
Int J Chron Obstruct Pulmon Dis; 2016; 11():1129-37. PubMed ID: 27313452
[TBL] [Abstract][Full Text] [Related]
5. Fucosylated surfactant protein-D is a biomarker candidate for the development of chronic obstructive pulmonary disease.
Ito E; Oka R; Ishii T; Korekane H; Kurimoto A; Kizuka Y; Kitazume S; Ariki S; Takahashi M; Kuroki Y; Kida K; Taniguchi N
J Proteomics; 2015 Sep; 127(Pt B):386-94. PubMed ID: 26206179
[TBL] [Abstract][Full Text] [Related]
6. Pneumococcal Infection Aggravates Elastase-Induced Emphysema via Matrix Metalloproteinase 12 Overexpression.
Takahashi S; Ishii M; Namkoong H; Hegab AE; Asami T; Yagi K; Sasaki M; Haraguchi M; Sato M; Kameyama N; Asakura T; Suzuki S; Tasaka S; Iwata S; Hasegawa N; Betsuyaku T
J Infect Dis; 2016 Mar; 213(6):1018-30. PubMed ID: 26563237
[TBL] [Abstract][Full Text] [Related]
7. Association between markers of emphysema and more severe chronic obstructive pulmonary disease.
Boschetto P; Quintavalle S; Zeni E; Leprotti S; Potena A; Ballerin L; Papi A; Palladini G; Luisetti M; Annovazzi L; Iadarola P; De Rosa E; Fabbri LM; Mapp CE
Thorax; 2006 Dec; 61(12):1037-42. PubMed ID: 16769715
[TBL] [Abstract][Full Text] [Related]
8. Severity of chronic obstructive pulmonary disease with 'exacerbator with emphysema phenotype' is associated with potential biomarkers.
Hao W; Li M; Zhang Y; Zhang C; Wang P
Postgrad Med J; 2020 Jan; 96(1131):28-32. PubMed ID: 31375557
[TBL] [Abstract][Full Text] [Related]
9. Emphysematous phenotype is an independent predictor for frequent exacerbation of COPD.
Oh YM; Sheen SS; Park JH; Jin UR; Yoo JW; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Lee JS; Lee SD
Int J Tuberc Lung Dis; 2014 Dec; 18(12):1407-14. PubMed ID: 25517804
[TBL] [Abstract][Full Text] [Related]
10. Association of fucosyltransferase 8 (FUT8) polymorphism Thr267Lys with pulmonary emphysema.
Yamada M; Ishii T; Ikeda S; Naka-Mieno M; Tanaka N; Arai T; Kumasaka T; Gemma A; Kida K; Muramatsu M; Sawabe M
J Hum Genet; 2011 Dec; 56(12):857-60. PubMed ID: 22011814
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase-9 predicts pulmonary status declines in α1-antitrypsin deficiency.
Omachi TA; Eisner MD; Rames A; Markovtsova L; Blanc PD
Respir Res; 2011 Mar; 12(1):35. PubMed ID: 21429222
[TBL] [Abstract][Full Text] [Related]
12. MMP-8, MMP-9 and Neutrophil Elastase in Peripheral Blood and Exhaled Breath Condensate in COPD.
Sng JJ; Prazakova S; Thomas PS; Herbert C
COPD; 2017 Apr; 14(2):238-244. PubMed ID: 27880043
[TBL] [Abstract][Full Text] [Related]
13. A keratan sulfate disaccharide prevents inflammation and the progression of emphysema in murine models.
Gao C; Fujinawa R; Yoshida T; Ueno M; Ota F; Kizuka Y; Hirayama T; Korekane H; Kitazume S; Maeno T; Ohtsubo K; Yoshida K; Yamaguchi Y; Lepenies B; Aretz J; Rademacher C; Kabata H; Hegab AE; Seeberger PH; Betsuyaku T; Kida K; Taniguchi N
Am J Physiol Lung Cell Mol Physiol; 2017 Feb; 312(2):L268-L276. PubMed ID: 28011617
[TBL] [Abstract][Full Text] [Related]
14. Identification of MMP-9 as a biomarker for detecting progression of chronic obstructive pulmonary disease.
Abd El-Fatah MF; Ghazy MA; Mostafa MS; El-Attar MM; Osman A
Biochem Cell Biol; 2015 Dec; 93(6):541-7. PubMed ID: 26291981
[TBL] [Abstract][Full Text] [Related]
15. Concomitant elevations of MMP-9, NGAL, proMMP-9/NGAL and neutrophil elastase in serum of smokers with chronic obstructive pulmonary disease.
Bchir S; Nasr HB; Bouchet S; Benzarti M; Garrouch A; Tabka Z; Susin S; Chahed K; Bauvois B
J Cell Mol Med; 2017 Jul; 21(7):1280-1291. PubMed ID: 28004483
[TBL] [Abstract][Full Text] [Related]
16. MMP-9 protein level does not reflect overall MMP activity in the airways of patients with COPD.
Lowrey GE; Henderson N; Blakey JD; Corne JM; Johnson SR
Respir Med; 2008 Jun; 102(6):845-51. PubMed ID: 18328682
[TBL] [Abstract][Full Text] [Related]
17. Annexin V decreases PS-mediated macrophage efferocytosis and deteriorates elastase-induced pulmonary emphysema in mice.
Yoshida S; Minematsu N; Chubachi S; Nakamura H; Miyazaki M; Tsuduki K; Takahashi S; Miyasho T; Iwabuchi T; Takamiya R; Tateno H; Mouded M; Shapiro SD; Asano K; Betsuyaku T
Am J Physiol Lung Cell Mol Physiol; 2012 Nov; 303(10):L852-60. PubMed ID: 22962014
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of leukocyte immunoglobulin-like receptor B4 on interstitial macrophages in COPD; their possible protective role against emphysema formation.
Mitsune A; Yamada M; Fujino N; Numakura T; Ichikawa T; Suzuki A; Matsumoto S; Mitsuhashi Y; Itakura K; Makiguchi T; Koarai A; Tamada T; Endo S; Takai T; Okada Y; Suzuki S; Ichinose M; Sugiura H
Respir Res; 2021 Aug; 22(1):232. PubMed ID: 34425800
[TBL] [Abstract][Full Text] [Related]
19. Metabolomics screening identifies reduced L-carnitine to be associated with progressive emphysema.
Conlon TM; Bartel J; Ballweg K; Günter S; Prehn C; Krumsiek J; Meiners S; Theis FJ; Adamski J; Eickelberg O; Yildirim AÖ
Clin Sci (Lond); 2016 Feb; 130(4):273-87. PubMed ID: 26564208
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis inhibitor of macrophage (AIM)/CD5L is involved in the pathogenesis of COPD.
Takimoto-Sato M; Suzuki M; Kimura H; Ge H; Matsumoto M; Makita H; Arai S; Miyazaki T; Nishimura M; Konno S
Respir Res; 2023 Aug; 24(1):201. PubMed ID: 37592330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
